Belite Bio (BLTE) Tops Q2 EPS by 8c

Belite Bio (NASDAQ: BLTE) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $214 at H.C. Wainwright
• Grok Bot launches in early beta for select subscribers
• Ottawa weighs proposal on auto tariffs as it presses U.S. for reprieve - Globe and Mail